Most patients qualify if they have a BMI of 30 or higher, or 27 and above with a weight related condition like high blood pressure or type 2 diabetes
Surgeons should proceed with full-stomach precautions in patients with no GI symptoms that did not hold GLP-1s
the level of ROS can be dramatically increased by external stimuli or internal stresses and can be toxic to cells [26]
No, the overall cancer rates are not higher in GLP-1 users
Peptide therapy works by targeting specific receptors in the body that regulate different functions, such as metabolism, muscle recovery, and fat burning
Self-administration can carry risks such as infection, allergic reactions, improper dosing, pain, bruising, and unexpected side effects